In contrast to the plethora of information about mutations in the TGFβ signal cascade in colon, gastric and pancreatic cancers [2], [11]–[13], the contribution of perturbed TGFβ signalling in oesophageal adenocarcinoma has not been elucidated completely. This evidence concerns the gene TGFB1 and pancreatic neoplasm.